Market Research Report

Meticulous Research ® —a leading global market research company, published a research report titled,  ‘ Point-of-care Diagnostics Market  by Application (Influenza, Pneumonia, COVID-19, TB, HAI, Hepatitis, HIV, Glucose, Coagulation, Hematology, Cancer, Cardiac), Platform, Purchase Mode (Prescription, OTC), End User (Home Care, Hospital)—Global Forecast to 2029. ’ According to this latest publication from Meticulous Research ® , the point-of-care diagnostics market is expected to reach $82.74 billion by 2029, at a CAGR of 7.4%. The growth of this market is driven by the increasing prevalence of chronic diseases and the rapidly growing demand for cost-effective and innovative POC diagnostic products. Point-of-care Diagnostics Market: Future Outlook The point-of-care diagnostics market is segmented based on Application (Infectious Disease Testing {Respiratory Infections Testing [Influenza, Tuberculosis, Pneumonia, Other Respiratory Infections], Healthcare-Associated Infecti...

  In Latin America, chronic infectious diseases caused by bacterial and viral pathogens are rising. Factors such as changing climatic conditions, increasing population, migration & mobility, and poor public health resources are causing this phenomenon. The pathogenic agents that cause emerging and re-emerging diseases in Latin America include bacterial pathogens (Salmonella enteritidis, Salmonella typhimurium, Salmonella typhi, Brucellaabortus, and Klebsiella pneumonia) and viral pathogens (HPV, HIV, EBV, Zika, and Chikungunya). Leprosy, dengue, leishmaniasis, HIV, Chagas disease, COVID-19 disease, and cancer are some of the prevalent diseases in this region. Chagas disease, a potentially life-threatening illness, is found mainly in the endemic areas of 21 Latin American countries. The parasites of this disease are transmitted by contact with feces/urine of infected blood-sucking triatomine bugs. Chagas disease is a neglected tropical disease (NTD) caused by the protozoan paras...